Jayastu Senapati: Contemporary Outcomes of Octa‐Nonagenarians with ND-AML
Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center, shared a post on X about a recent article he and his colleagues co-authored published in ACS Journal Cancer:
“Check out our manuscript, just published in ACS Journal Cancer describing the ‘Contemporary outcomes of octa‐nonagenarians with ND-AML,’ possibly the largest analysis in this high-risk but commonly encountered age group in AML.
- Subgroups of patients with Venetoclax sensitive disease biology: NPM1, IDH1/2 mutations, S related mutations
- OS >1 year in 28% patients overall
- Early mortality (<4 weeks) in 12% patients: higher incidence in patients with poor ECOG PS”
Title: Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia
Authors: Jayastu Senapati, Hagop M. Kantarjian, Tapan M. Kadia, Jeannot Kekedjian, Gautam Borthakur, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Prithviraj Bose, Nicholas J. Short, Musa Yilmaz, Nitin Jain, Naveen Pemmaraju, Hussein A. Abbas, Ghayas C. Issa, Abhishek Maiti, Guillermo Montalban Bravo, Indraneel Deshmukh, Elizabeth Shpall, Partow Kebriaei, Uday Popat, Sanam Loghavi, Beenu Thakral, Guilin Tang, Fadi G. Haddad, Yesid Alvarado, Guillermo Garcia Manero, Farhad Ravandi
Read the Full Article on ACS Journal Cancer
More posts featuring Jayastu Senapati.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023